Hintergrund: Angst- und depressive Störungen sind die häufigsten psychischen Störungen im Jugendalter und weisen untereinander eine hohe Komorbiditätsrate auf. Während kognitive Verhaltenstherapie (KVT) in der Behandlung von Angststörungen bei Jugendlichen wirksam ist, weist die Behandlung von depressiven Störungen nur mo-derate Wirksamkeit auf. Es liegen jedoch kaum Studien vor, die die Wirksamkeit der KVT in der Behandlung komorbid vorliegender Angst- und depressiver Störungen bei Jugendlichen untersuchen. Der transdiagnostische Ansatz des Unified Protocols (UP) für emotionale Störungen konnte seine Wirksamkeit im englischsprachigen Raum bereits im Jugend- und Erwachsenenalter nachweisen. Eine deutsche Übersetzung und Überprüfung des UP für Jugendliche steht bislang noch aus. Falldarstellung: In dieser Kasuistik wird eine 17-jährige Patientin vorgestellt, die die Kriterien einer sozialen Angststörung nach ICD-10 und DSM-5 erfüllt und zudem eine depressive Symptomatik aufweist. Nach einer umfassenden Diagnostik mithilfe eines strukturierten klinischen Interviews und Selbstberichtverfahrens wurden 17 Sitzungen KVT basierend auf dem UP für Adoleszente (UP-A) durchgeführt. Ziel der vorliegenden Fallbeschreibung ist die Vorstellung des Therapierationals und der Umsetzung des Manuals. Nach der Therapie erfüllte die Jugendliche die Kriterien der sozialen Angststörung nicht mehr, es zeigte sich zudem eine Abnahme der depressiven Symptomatik. Schlussfolgerungen: Die Fallvorstellung verweist auf die Umsetzbarkeit der deutschen Übersetzung des UP-A für die transdiagnostische Behandlung von Angst- und depressiven Störungen bei Jugendlichen. Eine randomisiert kontrollierte Studie zur Wirksamkeitsprüfung steht noch aus.

1.
Axelson
DA
,
Birmaher
B
.
Relation between anxiety and depressive disorders in childhood and adolescence
.
Depress Anxiety
.
2001
;
14
(
2
):
67
78
.
[PubMed]
1091-4269
2.
Barlow
DH
,
Ellard
KK
,
Fairholme
CP
,
Farchione
TJ
,
Boisseau
CL
,
Allen
LB
, et al.
The unified protocol for transdiagnostic treatment of emotional disorders: Client workbook
.
New York
:
Oxford University Press
;
2011
.
3.
Berman
SL
,
Weems
CF
,
Silverman
WK
,
Kurtines
WM
.
Predictors of outcome in exposure-based cognitive and behavioral treatments for phobic and anxiety disorders in children
.
Behav Ther
.
2000
;
31
(
4
):
713
31
. 0005-7894
4.
Bilek
EL
,
Ehrenreich-May
J
.
An open trial investigation of a transdiagnostic group treatment for children with anxiety and depressive symptoms
.
Behav Ther
.
2012
Dec
;
43
(
4
):
887
97
.
[PubMed]
0005-7894
5.
Boettcher
J
,
Schaeuffele
C
,
Renneberg
B
.
Das Unified Protocol zur Behandlung emotionaler Störungen
.
Psychotherapeut
.
2018
;
63
(
3
):
182
7
. 0935-6185
6.
Brown
TA
,
Chorpita
BF
,
Barlow
DH
.
Structural relationships among dimensions of the DSM-IV anxiety and mood disorders and dimensions of negative affect, positive affect, and autonomic arousal
.
J Abnorm Psychol
.
1998
May
;
107
(
2
):
179
92
.
[PubMed]
0021-843X
7.
Campbell-Sills
L
,
Barlow
DH
,
Brown
TA
,
Hofmann
SG
.
Effects of suppression and acceptance on emotional responses of individuals with anxiety and mood disorders
.
Behav Res Ther
.
2006
Sep
;
44
(
9
):
1251
63
.
[PubMed]
0005-7967
8.
Canals
J
,
Voltas
N
,
Hernández-Martínez
C
,
Cosi
S
,
Arija
V
.
Prevalence of DSM-5 anxiety disorders, comorbidity, and persistence of symptoms in Spanish early adolescents
.
Eur Child Adolesc Psychiatry
.
2019
Jan
;
28
(
1
):
131
43
.
[PubMed]
1018-8827
9.
Chorpita
BF
.
The tripartite model and dimensions of anxiety and depression: an examination of structure in a large school sample
.
J Abnorm Child Psychol
.
2002
Apr
;
30
(
2
):
177
90
.
[PubMed]
0091-0627
10.
Chorpita
BF
,
Barlow
DH
.
The development of anxiety: the role of control in the early environment
.
Psychol Bull
.
1998
Jul
;
124
(
1
):
3
21
.
[PubMed]
0033-2909
11.
Copeland
WE
,
Angold
A
,
Shanahan
L
,
Costello
EJ
.
Longitudinal patterns of anxiety from childhood to adulthood: the Great Smoky Mountains Study
.
J Am Acad Child Adolesc Psychiatry
.
2014
Jan
;
53
(
1
):
21
33
.
[PubMed]
0890-8567
12.
Costello
EJ
,
Mustillo
S
,
Erkanli
A
,
Keeler
G
,
Angold
A
.
Prevalence and development of psychiatric disorders in childhood and adolescence
.
Arch Gen Psychiatry
.
2003
Aug
;
60
(
8
):
837
44
.
[PubMed]
0003-990X
13.
Craske
M
.
Optimizing exposure therapy for anxiety disorders: an inhibitory learning and inhibitory regulation approach
.
Verhaltenstherapie
.
2015
;
25
(
2
):
134
43
. 1016-6262
14.
Craske
MG
,
Treanor
M
,
Conway
CC
,
Zbozinek
T
,
Vervliet
B
.
Maximizing exposure therapy: an inhibitory learning approach
.
Behav Res Ther
.
2014
Jul
;
58
:
10
23
.
[PubMed]
0005-7967
15.
Dalgleish
T
,
Watts
FN
.
Biases of attention and memory in disorders of anxiety and depression
.
Clin Psychol Rev
.
1990
;
10
(
5
):
589
604
. 0272-7358
16.
Döpfner
M
,
Plück
J
,
Kinnen
C
.
Arbeitsgruppe Deutsche Child Behavior Checklist: CBCL/6-18R, TRF/6-18R,YSR/11-18R. Deutsche Schulalter-Formen der Child Behavior Checklist von Thomas M. Achenbach
.
Göttingen
:
Hogrefe
;
2014
.
17.
Ehrenreich
JT
,
Goldstein
CM
,
Wright
LR
,
Barlow
DH
.
Development of a unified protocol for the treatment of emotional disorders in youth
.
Child Fam Behav Ther
.
2009
Jan
;
31
(
1
):
20
37
.
[PubMed]
0731-7107
18.
Ehrenreich-May
J
,
Queen
AH
,
Bilek
EL
,
Remmes
CS
,
Marciel
KK
. The unified protocols for the treatment of emotional disorders in children and adolescents. In:
Ehrenreich-May
J
,
Chu
BC
, editors
.
Transdiagnostic treatments for children and adolescents: Principles and practice
.
New York
:
Guilford Press
;
2013
. pp.
267
92
.
19.
Ehrenreich-May
J
,
Rosenfield
D
,
Queen
AH
,
Kennedy
SM
,
Remmes
CS
,
Barlow
DH
.
An initial waitlist-controlled trial of the unified protocol for the treatment of emotional disorders in adolescents
.
J Anxiety Disord
.
2017
Mar
;
46
:
46
55
.
[PubMed]
0887-6185
20.
Gratz KL, Roemer L. Multidimensional assessment of emotion regulation and dysregulation: Development, factor structure, and initial validation of the Difficulties in Emotion Regulation Scale. J Psychopathol Behav Assess. 2004;26(1):41–54.
21.
Gutzweiler
R
,
In-Albon
T
.
Überprüfung der Gütekriterien der deutschen Version der Difficulties in Emotion Regulation Scale in einer klinischen und einer Schülerstichprobe Jugendlicher
.
Z Klin Psychol Psychother
.
2018
;
47
(
4
):
274
86
. 1616-3443
22.
Gutzweiler
R
,
Schwarz
D
,
In-Albon
T
.
Pilot trial of the German version of the Unified Protocol for transdiagnostic treatment for emotional disorders in Adolescents
.
UP-A
;
2019
.
23.
Hautzinger M, Keller F, Kühner C. BDI-II. Beck Depressions-Inventar. Revision. Manual. 2nd ed. Frankfurt am Main: Harcourt Test Services GmbH; 2009.
24.
Hudson
JL
,
Keers
R
,
Roberts
S
,
Coleman
JR
,
Breen
G
,
Arendt
K
, et al.
Clinical predictors of response to cognitive-behavioral therapy in pediatric anxiety disorders: the Genes for Treatment (GxT) study
.
J Am Acad Child Adolesc Psychiatry
.
2015
Jun
;
54
(
6
):
454
63
.
[PubMed]
0890-8567
25.
In-Albon
T
, editor
.
Emotionsregulation und psychische Störungen im Kindes- und Jugendalter: Grundlagen, Forschung und Behandlungsansätze
.
Stuttgart
:
Kohlhammer
;
2013
.
26.
In-Albon
T
,
Schneider
S
.
Psychotherapy of childhood anxiety disorders: A meta-analysis
.
Psychother Psychosom
.
2007
;
76
(
1
):
15
24
.
[PubMed]
0033-3190
27.
Jacobson
NS
,
Truax
P
.
Clinical significance: a statistical approach to defining meaningful change in psychotherapy research
.
J Consult Clin Psychol
.
1991
Feb
;
59
(
1
):
12
9
.
[PubMed]
0022-006X
28.
Kennedy
SM
,
Tonarely
NA
,
Sherman
JA
,
Ehrenreich-May
J
.
Predictors of treatment outcome for the unified protocol for transdiagnostic treatment of emotional disorders in children (UP-C)
.
J Anxiety Disord
.
2018
Jun
;
57
:
66
75
.
[PubMed]
0887-6185
29.
Kessler
RC
,
Avenevoli
S
,
Costello
J
,
Green
JG
,
Gruber
MJ
,
McLaughlin
KA
, et al.
Severity of 12-month DSM-IV disorders in the national comorbidity survey replication adolescent supplement
.
Arch Gen Psychiatry
.
2012
a
Apr
;
69
(
4
):
381
9
.
[PubMed]
0003-990X
30.
Kessler
RC
,
Berglund
P
,
Demler
O
,
Jin
R
,
Merikangas
KR
,
Walters
EE
.
Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication
.
Arch Gen Psychiatry
.
2005
Jun
;
62
(
6
):
593
602
.
[PubMed]
0003-990X
31.
Kessler
RC
,
Petukhova
M
,
Sampson
NA
,
Zaslavsky
AM
,
Wittchen
HU
.
Twelve-month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States
.
Int J Methods Psychiatr Res
.
2012
b
Sep
;
21
(
3
):
169
84
.
[PubMed]
1049-8931
32.
Klipker
K
,
Baumgarten
F
,
Göbel
K
,
Lampert
T
,
Hölling
H
.
Psychische Auffälligkeiten bei Kindern und Jugendlichen in Deutschland – Querschnittergebnisse aus KiGGS Welle 2 und Trends
.
J Health Monit
.
2018
;
3
:
37
45
.
33.
Kodal
A
,
Fjermestad
K
,
Bjelland
I
,
Gjestad
R
,
Öst
LG
,
Bjaastad
JF
, et al.
Long-term effectiveness of cognitive behavioral therapy for youth with anxiety disorders
.
J Anxiety Disord
.
2018
b
Jan
;
53
:
58
67
.
[PubMed]
0887-6185
34.
Kodal
A
,
Fjermestad
KW
,
Bjelland
I
,
Gjestad
R
,
Öst
LG
,
Bjaastad
JF
, et al.
Predictors of long-term outcome of CBT for youth with anxiety disorders treated in community clinics
.
J Anxiety Disord
.
2018
a
Oct
;
59
:
53
63
.
[PubMed]
0887-6185
35.
Koyuncu
A
,
İnce
E
,
Ertekin
E
,
Tükel
R
.
Comorbidity in social anxiety disorder: diagnostic and therapeutic challenges
.
Drugs Context
.
2019
Apr
;
8
:
212573
.
[PubMed]
1745-1981
36.
Lahey
BB
,
Zald
DH
,
Perkins
SF
,
Villalta-Gil
V
,
Werts
KB
,
Van Hulle
CA
, et al.
Measuring the hierarchical general factor model of psychopathology in young adults
.
Int J Methods Psychiatr Res
.
2018
Mar
;
27
(
1
):
e1593
.
[PubMed]
1049-8931
37.
Lambert
MJ
,
Ogles
BM
.
Using clinical significance in psychotherapy outcome research: the need for a common procedure and validity data
.
Psychother Res
.
2009
Jul
;
19
(
4-5
):
493
501
.
[PubMed]
1050-3307
38.
Lampert
T
,
Prütz
F
,
Rommel
A
,
Kuntz
B
.
Soziale Unterschiede in der Inanspruchnahme medizinischer Leistungen von Kindern und Jugendlichen in Deutschland – Querschnittergebnisse aus KiGGS Welle 2
.
J Health Monit
.
2018
;
3
:
38
56
.
39.
Lewinsohn
PM
,
Rohde
P
,
Seeley
JR
;
The Clinical Consequences of Comorbidity
.
Adolescent psychopathology: III. The clinical consequences of comorbidity
.
J Am Acad Child Adolesc Psychiatry
.
1995
Apr
;
34
(
4
):
510
9
.
[PubMed]
0890-8567
40.
Mattejat F, Remschmidt H. ILK - Inventar zur Erfassung der Lebensqualität bei Kindern und Jugendlichen. Bern: Huber Verlag; 2006.
41.
Melfsen
S
,
Florin
I
,
Warnke
A
.
Sozialphobie und -angstinventar für Kinder
.
Göttingen
:
Hogrefe
;
2001
.
42.
Mohammadi
MR
,
Salehi
M
,
Khaleghi
A
,
Hooshyari
Z
,
Mostafavi
SA
,
Ahmadi
N
, et al.
Social anxiety disorder among children and adolescents: A nationwide survey of prevalence, socio-demographic characteristics, risk factors and co-morbidities
.
J Affect Disord
.
2020
Feb
;
263
:
450
7
.
[PubMed]
0165-0327
43.
O’Neil
KA
,
Kendall
PC
.
Role of comorbid depression and co-occurring depressive symptoms in outcomes for anxiety-disordered youth treated with cognitive-behavioral therapy
.
Child Fam Behav Ther
.
2012
;
34
(
3
):
197
209
. 0731-7107
44.
O’Neil
KA
,
Podell
JL
,
Benjamin
CL
,
Kendall
PC
.
Comorbid depressive disorders in anxiety-disordered youth: demographic, clinical, and family characteristics
.
Child Psychiatry Hum Dev
.
2010
Jun
;
41
(
3
):
330
41
.
[PubMed]
0009-398X
45.
Ohayon
MM
,
Schatzberg
AF
.
Social phobia and depression: prevalence and comorbidity
.
J Psychosom Res
.
2010
Mar
;
68
(
3
):
235
43
.
[PubMed]
0022-3999
46.
Polanczyk
GV
,
Salum
GA
,
Sugaya
LS
,
Caye
A
,
Rohde
LA
.
Annual research review: A meta-analysis of the worldwide prevalence of mental disorders in children and adolescents
.
J Child Psychol Psychiatry
.
2015
Mar
;
56
(
3
):
345
65
.
[PubMed]
0021-9630
47.
Remschmidt
H
,
Schmidt
MH
,
Poustka
F
.
Multiaxiales Klassifikationsschema für psychische Störungen des Kindes- und Jugendalters nach ICD-10
. 7th ed.
Göttingen
:
Hogrefe
;
2017
.
48.
Reynolds
S
,
Wilson
C
,
Austin
J
,
Hooper
L
.
Effects of psychotherapy for anxiety in children and adolescents: a meta-analytic review
.
Clin Psychol Rev
.
2012
Jun
;
32
(
4
):
251
62
.
[PubMed]
0272-7358
49.
Schneider
S
,
Pflug
V
,
In-Albon
T
,
Margraf
J
: Kinder-DIPS Open Access: Diagnostisches Interview bei psychischen Störungen im Kindes- und Jugendalter [Internet], Bochum, Forschungs- und Behandlungszentrum für psychische Gesundheit, Ruhr-Universität Bochum,
2017
.Available from: doi:
50.
Schwarz
D
,
Gutzweiler
R
,
In-Albon
T
.
Transdiagnostische Behandlung emotionaler Störungen in der Adoleszenz
.
Unveröffentlichtes Manuskript., Landau, Universität Koblenz-Landau
;
2018
.
51.
Seggar LB, Lambert MJ, Hansen NB. Assessing clinical significance: Application to the Beck Depression Inventory. Behav Ther. 2002;33(2):253–69
52.
Sherman
JA
,
Tonarely
NA
,
Ehrenreich-May
J
.
Targeting comorbid anxiety and depression using the Unified Protocol for transdiagnostic treatment of emotional disorders in adolescents
.
Clin Case Stud
.
2018
;
17
(
2
):
59
76
. 1552-3802
53.
Silverman
WK
,
Pina
AA
,
Viswesvaran
C
.
Evidence-based psychosocial treatments for phobic and anxiety disorders in children and adolescents
.
J Clin Child Adolesc Psychol
.
2008
Jan
;
37
(
1
):
105
30
.
[PubMed]
1537-4416
54.
Victor
SE
,
Klonsky
ED
.
Validation of a brief version of the Difficulties in Emotion Regulation Scale (DERS-18) in five samples
.
J Psychopathol Behav Assess
.
2016
;
38
(
4
):
582
9
. 0882-2689
55.
Weisz
JR
,
Kuppens
S
,
Ng
MY
,
Eckshtain
D
,
Ugueto
AM
,
Vaughn-Coaxum
R
, et al.
What five decades of research tells us about the effects of youth psychological therapy: A multilevel meta-analysis and implications for science and practice
.
Am Psychol
.
2017
Feb-Mar
;
72
(
2
):
79
117
.
[PubMed]
0003-066X
56.
Weisz
JR
,
Kuppens
S
,
Ng
MY
,
Vaughn-Coaxum
RA
,
Ugueto
AM
,
Eckshtain
D
, et al.
Are psychotherapies for young people growing stronger? Tracking trends over time for youth anxiety, depression, attention-deficit/hyperactivity disorder, and conduct problems
.
Perspect Psychol Sci
.
2018
;
•••
:
1745691618805436
.
[PubMed]
1745-6916
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.